StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
FF.MI$8.84-3.07%
Fair $8.84+0.0%

FF.MI

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Consumer Defensive / Packaged FoodsMilan

$8.84

-0.28 (-3.07%)

Fairly Valued+0.0%Fair Value $8.84Fund rank 27/100 · Data gapFallback financials|
SA 44/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-329751.00 · quality 47.0/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 21/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

44/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · FF.MILocal privado en este navegador · Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$203M

P/E

31.6x

↑

EV/EBITDA

7.6x

↓

ROE

7.5%

↑

Gross Margin

44.8%

↑

Debt/Equity

0.65

↑
52-Week Range$9
$7$12

TradingView lightweight chart

FF.MI price, volumen y niveles de valoración

Último $8.840Periodo -11.6%
Fair value: $8.840

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+6.8%

FCF CAGR

—

FCF margin

-1.7%

FCF / Net income

-0.42x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $252.1M · net income $10.1M · FCF $-4.2M

2022-FY → 2025-FY

Gross margin

44.8%+6.7% pts

Operating margin

6.8%+6.5% pts

Net margin

4.0%+8.6% pts

FCF margin

-1.7%+4.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$252.1M$252.1M$243.8M$251.8M$206.9M
Net Income$10.1M$10.1M$8.2M$-3.5M$-9.5M
EBITDA$34.5M$34.5M$30.9M$19.8M$3.3M
EPS0.410.410.32-0.14-0.37
Gross Margin44.8%44.8%42.1%37.2%38.1%
Operating Margin6.8%6.8%6.3%2.9%0.3%
Net Margin4.0%4.0%3.3%-1.4%-4.6%
Balance Sheet
Debt/Equity0.650.650.410.520.90
Current Ratio1.561.56———
Cash Flow
Free Cash Flow$-4.2M$-4.2M$11.1M$-329751.00$-12.3M
Returns
ROE7.5%7.5%6.2%-2.8%-7.1%
Valuation
P/E31.5731.5723.87——
EV/EBITDA7.637.637.4413.3097.61
P/B1.601.601.471.701.60
Growth & Yield
Revenue Growth3.4%3.4%-3.2%21.7%—
EPS Growth28.1%28.1%328.6%62.2%—
Dividend Yield1.8%1.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

24.1%

exigente

EPS terminal req.

$0.78

Spread vs growth

4.0%

5Y implied EPS CAGR

18.3%

exigente

EPS terminal req.

$0.95

Spread vs growth

9.8%

10Y implied EPS CAGR

14.1%

razonable

EPS terminal req.

$1.53

Spread vs growth

14.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +21.6%

Total return

+21.6%

Start / end P/E

23.1x → 21.6x

EPS bridge

0.32 → 0.41

Residual

-1.8%

EPS growth+28.1%
Multiple rerating-6.5%
Dividend+1.8%
Residual / FX / buybacks / cross-term-1.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.